Skip to main content
Contact Us
Subscribe
E-Edition
68°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about INCY
Recent news which mentions INCY
< Previous
1
2
3
4
5
6
7
Next >
Analyst Ratings for Incyte
August 02, 2023
Tickers
INCY
Tags
INCY
Market News
Benzinga
From
Benzinga
Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share
August 01, 2023
Tickers
INCY
Tags
Benzinga
General
Briefs
From
Benzinga
Incyte's Earnings Outlook
July 31, 2023
Tickers
INCY
Tags
INCY
Market News
Earnings
From
Benzinga
Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings
July 25, 2023
Tickers
ACCD
AIR
ARKQ
ARKW
Tags
KTOS
ARKQ
Coinbase
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
July 25, 2023
Tickers
ABBV
AGLE
AI
AVNS
Tags
RXT
ZS
NOGN
From
Benzinga
Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End
July 24, 2023
Tickers
INCY
SNDX
Tags
INCY
Health Care
Market News
From
Benzinga
'I Don't Want You To Touch That': Cramer Rejects Stock Down 32% Over Past Month, Prefers Tesla
July 19, 2023
Tickers
ARE
ASTS
CNC
FRT
Tags
ASTS
Trading Ideas
HUM
From
Benzinga
Incyte Skin Disease Drug Meets Primary Goal In Late-Stage Study In Children
July 12, 2023
Tickers
INCY
Tags
Benzinga
General
News
From
Benzinga
Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape
July 11, 2023
Tickers
INCY
SNDX
Tags
Small Cap
SNDX
Analyst Ratings
From
Benzinga
2 Low-Priced Stocks That Could Make You Richer
June 26, 2023
Tickers
ACRS
AGEN
AXSM
BMY
Tags
AGEN
VKTX
ACRS
From
Motley Fool
The bull market has left these 20 companies behind, but they are primed for growth
June 13, 2023
Tickers
AAPL
AMZN
BLK
CI
Tags
GOOG
MTCH
ETSY
From
MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
May 04, 2023
Tickers
ABSI
BLDR
BLKB
CERE
Tags
QNST
IONS
TPVG
From
Benzinga
Why Incyte Shares Are Falling Today
May 02, 2023
Tickers
INCY
Tags
Hedge Funds
Earnings
Market News
From
Benzinga
Earnings Outlook For Incyte
May 01, 2023
Tickers
INCY
Tags
Earnings
Benzinga
BZI/EP
From
Benzinga
What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks
April 21, 2023
Tickers
CTIC
INCY
Tags
Benzinga
CTIC
General
From
Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
April 19, 2023
Tickers
ARGX
BGNE
BMRN
INCY
Tags
Market News
NASDAQ:BGNE,NASDAQ:INCY,NASDAQ:BMRN,NASDAQ:ARGX,NASDAQ:UTHR,NASDAQ:TECH,NASDAQ:LEGN
INCY
From
InvestorPlace
Ominous Death Cross Forms On Incyte's Chart
April 13, 2023
Tickers
INCY
Tags
Markets
INCY
Market News
From
Benzinga
Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target
April 10, 2023
Tickers
INCY
Tags
Analyst Ratings
Expert Ideas
INCY
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 10, 2023
April 10, 2023
Tickers
AMH
AVB
BBWI
BCE
Tags
ESS
XMTR
HBAN
From
Benzinga
Valero Energy To Rally 32%? Here Are 10 Other Analyst Forecasts For Monday
April 10, 2023
Tickers
BA
CLNN
CTLT
CWK
Tags
KMPR
HRI
Analyst Ratings
From
Benzinga
What 13 Analyst Ratings Have To Say About Incyte
March 28, 2023
Tickers
INCY
Tags
INCY
Market News
Benzinga
From
Benzinga
Second Setback For Incyte's LIMBER Program - Analyst Says 'Resolution Timelines Unclear To Assess Impact'
March 24, 2023
Tickers
INCY
Tags
Movers
Benzinga
News
From
Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
March 23, 2023
Tickers
INCY
MGNX
MKGAF
MKKGY
Tags
News
Large Cap
Briefs
From
Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
March 21, 2023
Tickers
BIIB
ESALY
HRMY
INCY
Tags
NASDAQ:BIIB,NYSE:INSP,NASDAQ:INCY,NYSE:LLY,NYSE:MCK,NYSE:MRK,NASDAQ:HRMY,OTCMKTS:ESALY
HRMY
MCK
From
InvestorPlace
Why Shares of MacroGenics Climbed Thursday
March 16, 2023
Tickers
INCY
MGNX
PRVB
Tags
MGNX
INCY
Recent Press Releases
From
Motley Fool
Analyst Expectations for Incyte's Future
March 07, 2023
Tickers
INCY
Tags
Benzinga
Analyst Ratings
BZI/AAR
From
Benzinga
Incyte Discontinues LIMBER-304 On Doubts Regarding Meeting Primary Goal, Analyst Says It Underpins Some Investor Concerns
March 06, 2023
Tickers
INCY
Tags
Health Care
INCY
Biotech
From
Benzinga
Why the stock market rally can keep going, says Wall Street strategist who only recently warned of a death zone.
March 06, 2023
Tickers
AAPL
AMC
AMZN
APE
Tags
CIEN
WW
FAST
From
MarketWatch
Incyte's Return On Capital Employed Overview
February 08, 2023
Tickers
INCY
Tags
INCY
Market News
Benzinga
From
Benzinga
Analyst Ratings for Incyte
February 08, 2023
Tickers
INCY
Tags
BZI/AAR
Analyst Ratings
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.